# Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis

> **NCT00043329** · — · COMPLETED · sponsor: **InterMune** · enrollment: 6 (actual)

## Conditions studied

- Osteopetrosis

## Interventions

- **DRUG:** Actimmune Registry

## Key facts

- **NCT ID:** NCT00043329
- **Lead sponsor:** InterMune
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2007-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043329, "Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00043329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*